LJ-01005

N/A

Report date: 2022/10/09 18:02:41

Base Information

Drug NameLJ-01005
Drug Alias NameLJ-01005
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsChronic UrticariaRhinitis, Allergic, Seasonal
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesChangchun Lanjiang Pharmaceutical Technology Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesChangchun Lanjiang Pharmaceutical Technology Co Ltd
Inactive CompaniesN/A
Active IndicationsChronic UrticariaRhinitis, Allergic, Seasonal
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A